A patent is a set of exclusive rights granted by a state (national government) to an inventor for a limited period of time in exchange for a public disclosure of an invention.
A patent is a set of exclusive rights granted by a state (national government) to an inventor for a limited period of time in exchange for a public disclosure of an invention.
NEWS FLASH: //Check our latest course offering on Patent-Business-Strategy over at Udemy here: http://www.udemy.com/patent-business-strategy/ with a 50 per cent launch discount //
This a discussion on patent infringement for academic purpose. Please do NOT consider this legal advice.
[Some material has not been updated for recent changes, so use it at your own risk]
Disclaimer: This is not legal advice.
The above presentation is a step to simplify the concept of Trademark in India.It also focuses on the process of registration under the Trademarks Act 1999.
The presentation simplifies the steps involved and makes it easier to understand the same.
Note:-The following presentation is a general writing containing contents derived from basic knowledge and relevant books and articles.Also it is the original work of the writer.
Intellectual property, very broadly, means the legal rights which result from intellectual activity in the industrial, scientific, literary and artistic fields.
Intellectual property law aims at safeguarding creators and other producers of intellectual goods and services by granting them certain time-limited rights to control the use made of those productions.
Intellectual property is traditionally divided into two branches, “industrial property” and “copyright.” Patents come under the former category
Compulsory licensing is when a government allows someone else to produce a patented product or process without the consent of the patent owner or plans to use the patent-protected invention itself.
NEWS FLASH: //Check our latest course offering on Patent-Business-Strategy over at Udemy here: http://www.udemy.com/patent-business-strategy/ with a 50 per cent launch discount //
This a discussion on patent infringement for academic purpose. Please do NOT consider this legal advice.
[Some material has not been updated for recent changes, so use it at your own risk]
Disclaimer: This is not legal advice.
The above presentation is a step to simplify the concept of Trademark in India.It also focuses on the process of registration under the Trademarks Act 1999.
The presentation simplifies the steps involved and makes it easier to understand the same.
Note:-The following presentation is a general writing containing contents derived from basic knowledge and relevant books and articles.Also it is the original work of the writer.
Intellectual property, very broadly, means the legal rights which result from intellectual activity in the industrial, scientific, literary and artistic fields.
Intellectual property law aims at safeguarding creators and other producers of intellectual goods and services by granting them certain time-limited rights to control the use made of those productions.
Intellectual property is traditionally divided into two branches, “industrial property” and “copyright.” Patents come under the former category
Compulsory licensing is when a government allows someone else to produce a patented product or process without the consent of the patent owner or plans to use the patent-protected invention itself.
Patent your Food Innovation | Question whether or not food recipes can be patented: Yes, food recipes can be patented from inventor's viewpoint. Non provisional utility patent application can be filed before the patent office to secure patenting rights of the technology.
Strong Recipe Patent Claims should be Drafted by the food Patent Attorney. Patent tip would be write your patent claims and claim your patent parameters broadly in a range.
Classification of law - Legal Environment of business - Business Law - Manu M...manumelwin
Public Law is concerned with the legal relation between the state and the individuals. All laws relating to the distribution and exercise of power by the state are the part of public law.
India : Innovation and Patents Sector in Food Industry| Patent classified under A23
A23 (foods or foodstuffs; their treatment): Class A23 includes patents relating to, amongst others, preserving, edible oils of fats, coffee and tea, cocoa products, confectionery, fodder, protein compositions, and the shaping and working of foodstuffs.
The relevant sections of the Patent Act applicable for ascertaining patentability of food related invention are:
Section 3(c): the mere discovery of a scientific principle or the formulation of an abstract theory or discovery of any living thing or non-living substance occurring in nature.
Section 3(d): the mere discovery of a new form of a known substance, which does not result in the enhancement of the known efficacy of that substance or the mere discovery of any new property or new use for a known substance or mere use of a known process, machine or apparatus unless such known process results in a new product or employs at least one new reactant.
Section 3(i): any process for the medicinal, surgical, curative, prophylactic [diagnostic, therapeutic] or other treatment of human beings or any process for a similar treatment of animals to render them free of disease or to increase their economic value or that of their products;
Section 3(j):plants and animals in whole or any part thereof other than micro organisms but including seeds, varieties and species and essentially biological processes for production or propagation of plants and animals;
Advancement in research for improving the ambient temperature stability of a ...Arup Nag
An overview of my research in a Centre of Research Excellence in New Zealand to develop novel technology which successfuly enabled probiotic strains remain stable for longer duration under ambient storage conditions.
Genentech, Novartis, Monsanto, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA,
PIONEER HI-BRED INTERNATIONAL, INC., NOVARTIS AG, Monsanto Technology LLC,
ROCHE DIAGNOSTICS GMBH Top Patent filers & Patent recipients classified under the IPC C12.
Inventions in the field of Biochemistry & Genetic Engineering include-
Preparation of wine and other alcoholic beverages.
Preparation of Vinegar.
Apparatus for enzymology and microbiology.
Composition of microbes and enzymes.
Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
Installation of New CSD (Carbonated Soft Drink) RGB (Returnable Glass Bottle)...INFOGAIN PUBLICATION
The basic of this project was installation of new CSD (carbonated soft drink) RGB (returnable glass bottle) line with comply food safety and final validation of line. New manufacturing line installation deals with installation of all equipment and machine require for smooth running and producing CSD for COCA-COLA company (Coca-Cola, Thums UP, Limca) such as conveyer belt, uncasing machine, light inspection station, bottle washer EBI (electronic bottle inspection ) machine, Paramix, Filler, Sealer, Date coding machine, caser etc. During installation of machine we have fulfill requirement related to machine, work space, hygienic condition so that machine can work smoothly and deliver safe food product The main concern of doing this project was deliver a safe product to the consumer by applying HACCP and ISO22K. I have done hazard analysis and validation of this new installed line and identify CCP and OPRP which need to control by applying control measure.
Food supplements, agrochemicals, probiotic, cocoa based inventions and other food related tech domain patents in India before the indian patent office.
Novelty patent search or Patentability search is performed to determine if an invention meets the requirements of novelty, usefulness, and non-obviousness and is performed prior to the preparation of patent application by the patent expert.
Production, characterisation and value addition of dahi made from raw, pasteu...eSAT Publishing House
IJRET : International Journal of Research in Engineering and Technology is an international peer reviewed, online journal published by eSAT Publishing House for the enhancement of research in various disciplines of Engineering and Technology. The aim and scope of the journal is to provide an academic medium and an important reference for the advancement and dissemination of research results that support high-level learning, teaching and research in the fields of Engineering and Technology. We bring together Scientists, Academician, Field Engineers, Scholars and Students of related fields of Engineering and Technology
Experience the perfect balance of health and refreshment with our probiotics and prebiotics drinks. Crafted with precision and care, our beverages offer a delicious way to support digestive wellness and promote a flourishing gut microbiome. Each sip delivers a symphony of beneficial bacteria and nourishing prebiotic fibers, fostering overall well-being and vitality, one refreshing drink at a time.
https://www.blockchainailawyer.com/iprs Oracle Database is a trademark of Oracle Corporation, which is a leading provider of database software and cloud services. Oracle Database trademark applications are the legal documents that seek to register and protect the Oracle Database brand name and logo in various jurisdictions around the world.
Migrating Oracle Database trademark applications to cloud infrastructure means moving the data and processes related to these applications from on-premises servers or other cloud platforms to Oracle Cloud Infrastructure (OCI), which is Oracle’s next-generation cloud platform that offers high performance, security, scalability, and cost-efficiency for various workloads.
There are several advantages of migrating Oracle Database trademark applications to cloud infrastructure, such as:
Reducing the operational and maintenance costs of managing on-premises servers or other cloud platforms
Leveraging the advanced features and services of OCI, such as autonomous database, data management, analytics, integration, security, and identity
Enhancing the availability, reliability, and performance of the trademark applications and data
Simplifying the compliance and governance of the trademark applications and data across different regions and jurisdictions
Accelerating the innovation and development of new trademark applications and services
There are different methods and tools for migrating Oracle Database trademark applications to cloud infrastructure, depending on the source and target environments, the size and complexity of the data, and the migration objectives and requirements. Some of the common methods and tools are:
Oracle Data Pump: A utility that enables the export and import of data and metadata between Oracle databases, either on-premises or on OCI
Oracle GoldenGate: A software solution that enables the replication and synchronization of data and transactions across heterogeneous databases, either on-premises or on OCI
Oracle Zero Downtime Migration: A tool that automates the migration of Oracle databases from on-premises or other cloud platforms to OCI, with minimal or no downtime
Oracle Cloud Infrastructure Database Migration: A fully-managed service that provides a high-performing, self-service experience for migrating Oracle databases from on-premises, Oracle Cloud, or Amazon RDS to OCI
For more information about migrating Oracle Database trademark applications to cloud infrastructure, you can refer to the following resources:
Overview of Oracle Cloud Infrastructure Database Migration
About the Advantages of Migrating Custom Applications to Oracle Cloud
Learn about migrating Oracle Database Appliance workloads to the cloud
Learn About Migrating Application Data to the Cloud
METHOD AND SYSTEM FOR PREDICTING OPTIMAL LOAD FOR WHICH THE YIELD IS
MAXIMUM BY USING MULTIPLE INPUT ELECTROLYZER PARAMETERS filed by RIPIK TECHNOLOGY PRIVATE LIMITED
This patent describes a system to optimize operations in manufacturing facilities that use electrolyzers. Electrolyzers split water into hydrogen and oxygen using electricity. Their electrical load levels impact costs and efficiency.
The present invention uses AI and machine learning to predict the best way to allocate load across multiple electrolyzers. This maximizes total yield for the manufacturing plant while minimizing electricity costs.
It takes into account equipment factors like the capacity of each electrolyzer. It also considers constraints like raw material supply and product storage limits. The system models chlorine evacuation too since that can hinder caustic soda output.
The algorithms are capable of processing the many complex variables at play. No easy spreadsheet could accomplish this modeling. A type of mathematical optimization called "swarm optimization" is applied. Examples are genetic algorithms and particle swarm optimization.
The AI system keeps adapting its load recommendations based on data coming into its monitoring dashboard. Operators can customize certain parameters but the software is configuring most of the decision logic automatically.
The inventors claim results show their AI optimizer significantly cutting power consumption and costs versus alternatives. Smart coordination of multiple electrolyzers is complex. This technology handles the data analysis to efficiently divide load distribution.
In essence, the patent discloses an intelligent electrolyzer load prediction platform. It leverages AI to boost manufacturing performance while reducing electricity usage. Company managers can see optimized operations guidance on easy dashboard interfaces. It aims to save power, costs and effort through algorithmic process coordination.
The U.S. Food and Drug Administration (USFDA) regulates the use of food additives in the United States. Specifically, food additives are subject to regulation under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the regulations in Title 21 of the Code of Federal Regulations (21 CFR). These regulations define the conditions under which food additives, including acidity regulators like Orthophosphoric acid (Phosphoric Acid), can be used in food and beverages.
The specific regulations and allowable levels of Orthophosphoric acid in food and beverages, including gold drinks, can be found in the Code of Federal Regulations (21 CFR) Title 21, Part 182, which deals with substances generally recognized as safe (GRAS) for use in food. Orthophosphoric acid is covered in the section "21 CFR 182.1073 - Phosphoric acid" and its use in various food categories is outlined in this regulation.
For precise information on the allowable levels of Orthophosphoric acid in gold drinks or any other food and beverage products in the United States, it is advisable to refer to the specific regulations provided in 21 CFR 182.1073 and consult with the U.S. Food and Drug Administration (USFDA) or their official resources to ensure compliance with the most up-to-date regulations.
https://sciwri.club/archives/4288
Prity Khastgir is a techno-savvy patent attorney in India with 12 yrs of experience working with clients across the globe. Her areas of expertise are IP portfolio research, cross-border technology transactions, licensing agreements, product clearance, freedom-to-operate, patent infringement & invalidity analysis, research & opinions. Currently, she helps startups to raise funds, assists foreign companies to find right business partners in India. She also assists enterprises to enter and find the right angels, and VCs in Malaysia, Singapore, US, UK, Japan and India. Here, she answers questions about IP career prospects in India, in her Face-to-face interaction with Reetu Mehta.
Is Intellectual Property Rights (IPR) a good career option in India?
Before answering this question, I ask myself why I do what I do every morning. Am I passionate about my day? IPR is a fascinating field and apt for people who wants answers to questions related to what, why, when and how. IPR is a field of law protecting creations of mind in form of ideas, inventions, brands, trademarks, copyrights, software codes, industrial design registration and trade secrets. However, if research is not your cup of tea then please do not enter this field. You have to passionate about innovations. Many people enter this field because it is a high paying job in the long run compared to normal 9-5 jobs in India. However, not everyone will be able to sustain in this field in the long run. Therefore, be wise before entering this field. You should be fascinated by technologies around you, have a problem solving approach, and be compassionate towards your peers.
How can a life science PhD begin with career in IPR?
Life science is study of life processes. The scope of PhD in IPR is better as the person is familiar with research. The best way to move forward is to do online IPR courses and get an overview of IPR. One should have interest and passion to solve the queries related to the intellectual creations of mind. One should have problem solving approach as client is looking for solutions.
What are the required skill sets?
First and foremost, the person should have technology and legal acumen to understand innovations and have a research capability to work at least for 10-12 hours. Thinking out of the box to solve a research project is the key to assisting inventors to protect their inventions.
How does a career in IP evolve/grow in India?
The individuals I have come across are passionate about protecting innovations. To evolve in this field you have to be technology savvy. The Intellectual Property law has evolved a lot in last 10 years. Now a trademark can be registered in less than one month in India with proper documentation. The Indian government is giving a number of grants to startups in India to grow by leap and bounds.
What is the kind of work one is expected to do and what are the skill sets one can acquire over the course?
Trade Secret as Intellectual Property Strategic
Tool in Industry 4.0
Prity Khastgir
TCIS India, Level-5, Caddie Commercial Tower, Novotel Hotel, Hospitality District Aerocity,
IGI Airport, New Delhi 110037 India
khasip@khastgir.com
Abstract -- In covid situation, most businesses have reviewed
their existing contracts to understand scope of parties involved
and thereby Intellectual Property clauses and sub-clauses of any
contract or agreement become very important. Private blockchain
implementation in the current scenario is key to the maze to
protect trade secrets in a confidential manner.
Progressive IP strategy and partnering with right partners to
create and maintain sustainable development positions in the
market to serve customers and catering to their needs is the need
of the hour. Proactive strategic signed contracts and agreements
should be mandatory for smooth functioning of any start-up or
enterprise. Negotiation, Mediation and Arbitration are like trinity
in law to resolve any arising conflict.
Keywords: Intellectual Property, Trade secrets protection, Blockchain
implementation, Industry 4.0, Public domain
I. INTRODUCTION
EVERY technology launch contributes to macroeconomic
growth of the country. Contracts and agreements drafted around
technology licensing or assignments play a pivotal role as to
how developed innovation would be deployed in different
verticals. Over the last one decade, we have witnessed a very
strong nonlinear curve and especially with what forms part of
terms and conditions to exert control over under applicable
contract law while collaborating with different parties to
manage successful ventures in Industry 4.0 operating in
multiple jurisdictions and protecting trade secrets.
Primarily, contracts and proper agreements in place sets the
ambit right to protect trade secrets of technology driven startup ventures. Understanding Intellectual property landscape and
conducting IP due-diligence is very important and is essentially
a first step to understand short-term and long-term goals to
prepare rock solid IP strategy with a holistic viewpoint.
Intellect is the creation of the mind and protecting intellectual
capacity by utilizing different IPRs is key to deliver market cap
results. In covid situation, most businesses have reviewed their
existing contracts to understand scope of parties involved and
thereby Intellectual Property clauses and sub-clauses of any
t's quite unfair because laundering is taking place either domestic investors we can even take place by foreign investors. What kind of modification we could have done? Now you case capital investors of foreign investors what they have. Some of you are still asking me how do you calculate here. Fair market value for calculation is by a book value method or discounted cash flow method. In order to see examples of beginning for examination, basically calculate the fair market value. So you can see new budget proposal is applicable to capital raise from both as well as foreign. Taxi. Number 21. Venture capitalists and Angel investors are both safe. Companies considered startups were approved. Five years annual turnover? Not usually. The Startup India scheme is implemented by Ministry of Commerce and Industry. There is indeed implemented by Minister. No. The Angel Tax has been introduced for the first time in amendment to Income Tax Act. For the first time, Angel Tax is applicable to both Mr. and Mr. Companies. And the Angel facts made applicable to capital raised for more domestic and foreign investors kits. And there's investors now it is for both. This quarter. This tax is imposed only when the startup company is issuing shares at a price on the fair market price. It's a startup companies raising capital at a fair market value added taxes. The tax on long term debt. So recently the government has made certain changes to the spec long term capital gains tax on debt. Take this on long term capital gains tax on deposits. Let's look at this more capital gains. What is capital gains? Capital gains tax is the tax which people pay on profits which they make by selling. And whenever I sell an asset begin profit a part of that profit paid to commit tax capital gains, for example. I want to share at least in the year 15. I have shared and made a mistake to comment says if you have made pocket. Is capital gains tax will come into play if you make a loss? Your losses. Understand this concept of what is long term comes against that. Which takes money from investors and after taking money from investors, that money is invested in different different financial shares. So here we have predominantly more types of. Mutual funds are those funds. There mutual funds are investing more than 65% money in checks that mutual funds are. More than 65% of money is invested in bonds, which means it pretty much the funds can make investment in shares. Bonds. But where is the priority investment shares? They can make investment in both shares and bonds. Investment. On the equity mutual funds, we have short term capital gains tax and long term capital gains. Short term capital gains tax comes into play if I buy and sell. Long term capital gains tax will come into play if I buy and sell after. Play. March 2023, just in one year. And sending. You can. And. What is long term Complications? They're 2023. I bought it in March 2024. After more than one year. How much is it? Capital
xtell. Why September the 26th, I don't have a good picture, but I know for the first half the intelligence was saying it's gonna be a long war. He decided then to do it, and he had set it up so he could just say yes and a day later would blow away. You said it and say work by sonars. Frequency, you can blow them up, you can do it. So tough thing to do. And so why at that point, whether he was deciding is this is going to be a long war, it's going to cost a lot of money. I'm going to go all the way. He's now moving a lot of American troops and equipment into Poland. I don't know if he's going to commit native to it. I don't know if NATO wants to go, but he basically gave Chancellor Schultz, took away the option of Schultz to say I'm going to stop giving them arms. Winter's coming. I want that pipeline. I want to keep my people warm and wealthy. So he blew it up. So there's been a lot of news reporting, a lot of interest on this very simple question. Who blew up the North Stream pipelines? Remember in September of last year, the North Stream One and N Stream Two, which are two parallelly running pipelines carrying natural gas from Russia to Germany, were blown up. There were massive explosions which happened 250 feet are below the sea. Now the first report that came out, which was last month by a famous American journalist, which seemed to suggest that this was an inside job, it was carried out by the United States using state actors. now just this past week there's been some follow up reporting
September the 26th last year and. I there was no way. Common sense. You have to deal with common sense. Well, let's see. I knew that no Russia would have done it because of Putin already had responded. There's two major pipelines, N Stream one, which has been alive for since 2011, and Nord Stream two, which is. These are huge. They moved millions of whatever the measurement is of natural gas. There is a different measurement and it's not cubic feet, it's they they they move in, they mouth stream one turn Germany because they supplied cheap natural gas. That was very clear. Then they needed it anyway. I'm just giving you all this because I'm not here. I can answer your question, but I be coming from the blue one. I don't want to come from the blue. I want people to understand I've done this a long time. So the White House, Mr. Hush, they have rejected your story outright. They've called it a figment of your imagination. More fiction than fact is the wording that they used. Germany has also taken a very cautious mind on your story. You referred before in your first answer to Western media like the New York Times, The Washington Post. Had you taken your story to the editors there, would they have published such a consequential story basis, Just one single, unnamed anonymous source? How would you react to that? This source? Would I the way described the story and the intent of how I sourced it? Was to be as as vague as possible. It would have
Play with Data aka Magic
tell. Why September the 26th, I don't have a good picture, but I know for the first half the intelligence was saying it's gonna be a long war. He decided then to do it, and he had set it up so he could just say yes and a day later would blow away. You said it and say work by sonars. Frequency, you can blow them up, you can do it. So tough thing to do. And so why at that point, whether he was deciding is this is going to be a long war, it's going to cost a lot of money. I'm going to go all the way. He's now moving a lot of American troops and equipment into Poland. I don't know if he's going to commit native to it. I don't know if NATO wants to go, but he basically gave Chancellor Schultz, took away the option of Schultz to say I'm going to stop giving them arms. Winter's coming. I want that pipeline. I want to keep my people warm and wealthy. So he blew it up. So there's been a lot of news reporting, a lot of interest on this very simple question. Who blew up the North Stream pipelines? Remember in September of last year, the North Stream One and N Stream Two, which are two parallelly running pipelines carrying natural gas from Russia to Germany, were blown up. There were massive explosions which happened 250 feet are below the sea. Now the first report that came out, which was last month by a famous American journalist, which seemed to suggest that this was an inside job, it was carried out by the United States using state actors. now just this past week there's been some follow up reporting
September the 26th last year and. I there was no way. Common sense. You have to deal with common sense. Well, let's see. I knew that no Russia would have done it because of Putin already had responded. There's two major pipelines, N Stream one, which has been alive for since 2011, and Nord Stream two, which is. These are huge. They moved millions of whatever the measurement is of natural gas. There is a different measurement and it's not cubic feet, it's they they they move in, they mouth stream one turn Germany because they supplied cheap natural gas. That was very clear. Then they needed it anyway. I'm just giving you all this because I'm not here. I can answer your question, but I be coming from the blue one. I don't want to come from the blue. I want people to understand I've done this a long time. So the White House, Mr. Hush, they have rejected your story outright. They've called it a figment of your imagination. More fiction than fact is the wording that they used. Germany has also taken a very cautious mind on your story. You referred before in your first answer to Western media like the New York Times, The Washington Post. Had you taken your story to the editors there, would they have published such a consequential story basis, Just one single, unnamed anonymous source? How would you react to that? This source? Would I the way described the story and the intent of how I sourced it? Was to be as as vague as possible.
I know which you know. What is left? So I can close my eyes and enter into this and reach my office. So on a more serious note, I think. You cannot classify it as a treatment team or a team or you know, limited over 50. See Virat Kohli is good in 20, is good in limited over 20 Cricket is also good in Test cricket. So the RBI has to function and perform those fifty over match as well as in our effort. On effort and endeavor is always to optimize our for us to the best thing to extend that we can we put our best foot forward. Thank you very much. Thank you very much for accepting our condition. Great pleasure talking to you. Thank you very much and thank you very much for your patience. For short the time primarily for my longest answers. I can see your colleagues are very very efficient. But thank you once again. Thank you very much for your time. Thank you so much, Governor, and thank you again. Right for our next session. Welcome everyone And there's been talk about. Exciting transformations over the next several years will be the advent of Fight Jail India and this whole idea that India had. Physical. And it is an absolute delight to welcome for this fireside conversation to the Business Today India 100 Country Summit, one of the legendary. This generation. Quality and it's still standing fighting scale this in this fight can they have a popular as he walked through this Business Today and they have. Thank you so much. i want to start by asking you about the hearing which is about 5G everyone watching want We start at what does this mean? Everyone was listening to this. Fighting. And if you really look at the world fighting at most time to take roots, you know most of the Western world, Southeast Asian countries, Singapore and starts right as well I think we are some people think. Check this the perfect time some use cases. You can see devices coming through Priceline devices trying to find one perfectly from the country they can do so. I think we are ready. Thankfully this time the government put up a lot of spectrum because 5G requires made large chunks of spectrum to be effective. Otherwise they don't really get the joy of our friendship and not only the mid band which the seed bank claims. They're All in all, I think India is now ready from the spectrum point of view, but it's now standard and available. We have been building from this day for the last 24 months and predicted that we would want sometimes some of the preparedness felt that would probably come in 2021. But I think they're just takes time to develop the ecosystem. So we are ready. Expect launches October Believe will be from very early in October. Sometime in October you can start to see on your phones if there are any. We'll start with dictionaries, the key towns and the keep on as we've seen here earlier, keep on with right across and going into deep. What should you do to us, I mean today? Customer. Very important use cases which are developing around which took my mind are
tell. Why September the 26th, I don't have a good picture, but I know for the first half the intelligence was saying it's gonna be a long war. He decided then to do it, and he had set it up so he could just say yes and a day later would blow away. You said it and say work by sonars. Frequency, you can blow them up, you can do it. So tough thing to do. And so why at that point, whether he was deciding is this is going to be a long war, it's going to cost a lot of money. I'm going to go all the way. He's now moving a lot of American troops and equipment into Poland. I don't know if he's going to commit native to it. I don't know if NATO wants to go, but he basically gave Chancellor Schultz, took away the option of Schultz to say I'm going to stop giving them arms. Winter's coming. I want that pipeline. I want to keep my people warm and wealthy. So he blew it up. So there's been a lot of news reporting, a lot of interest on this very simple question. Who blew up the North Stream pipelines? Remember in September of last year, the North Stream One and N Stream Two, which are two parallelly running pipelines carrying natural gas from Russia to Germany, were blown up. There were massive explosions which happened 250 feet are below the sea. Now the first report that came out, which was last month by a famous American journalist, which seemed to suggest that this was an inside job, it was carried out by the United States using state actors. now just this past week there's been some follow up reporting
September the 26th last year and. I there was no way. Common sense. You have to deal with common sense. Well, let's see. I knew that no Russia would have done it because of Putin already had responded. There's two major pipelines, N Stream one, which has been alive for since 2011, and Nord Stream two, which is. These are huge. They moved millions of whatever the measurement is of natural gas. There is a different measurement and it's not cubic feet, it's they they they move in, they mouth stream one turn Germany because they supplied cheap natural gas. That was very clear. Then they needed it anyway. I'm just giving you all this because I'm not here. I can answer your question, but I be coming from the blue one. I don't want to come from the blue. I want people to understand I've done this a long time. So the White House, Mr. Hush, they have rejected your story outright. They've called it a figment of your imagination. More fiction than fact is the wording that they used. Germany has also taken a very cautious mind on your story. You referred before in your first answer to Western media like the New York Times, The Washington Post. Had you taken your story to the editors there, would they have published such a consequential story basis, Just one single, unnamed anonymous source? How would you react to that? This source? Would I the way described the story and the intent of how I sourced it? Was to be as as vague as possible. It would have been very
tell. Why September the 26th, I don't have a good picture, but I know for the first half the intelligence was saying it's gonna be a long war. He decided then to do it, and he had set it up so he could just say yes and a day later would blow away. You said it and say work by sonars. Frequency, you can blow them up, you can do it. So tough thing to do. And so why at that point, whether he was deciding is this is going to be a long war, it's going to cost a lot of money. I'm going to go all the way. He's now moving a lot of American troops and equipment into Poland. I don't know if he's going to commit native to it. I don't know if NATO wants to go, but he basically gave Chancellor Schultz, took away the option of Schultz to say I'm going to stop giving them arms. Winter's coming. I want that pipeline. I want to keep my people warm and wealthy. So he blew it up. So there's been a lot of news reporting, a lot of interest on this very simple question. Who blew up the North Stream pipelines? Remember in September of last year, the North Stream One and N Stream Two, which are two parallelly running pipelines carrying natural gas from Russia to Germany, were blown up. There were massive explosions which happened 250 feet are below the sea. Now the first report that came out, which was last month by a famous American journalist, which seemed to suggest that this was an inside job, it was carried out by the United States using state actors. now just this past week there's been some follow up reporting
September the 26th last year and. I there was no way. Common sense. You have to deal with common sense. Well, let's see. I knew that no Russia would have done it because of Putin already had responded. There's two major pipelines, N Stream one, which has been alive for since 2011, and Nord Stream two, which is. These are huge. They moved millions of whatever the measurement is of natural gas. There is a different measurement and it's not cubic feet, it's they they they move in, they mouth stream one turn Germany because they supplied cheap natural gas. That was very clear. Then they needed it anyway. I'm just giving you all this because I'm not here. I can answer your question, but I be coming from the blue one. I don't want to come from the blue. I want people to understand I've done this a long time. So the White House, Mr. Hush, they have rejected your story outright. They've called it a figment of your imagination. More fiction than fact is the wording that they used. Germany has also taken a very cautious mind on your story. You referred before in your first answer to Western media like the New York Times, The Washington Post. Had you taken your story to the editors there, would they have published such a consequential story basis, Just one single, unnamed anonymous source? How would you react to that? This source? Would I the way described the story and the intent of how I sourced it? Was to be as as vague as possible. It would have been
tell. Why September the 26th, I don't have a good picture, but I know for the first half the intelligence was saying it's gonna be a long war. He decided then to do it, and he had set it up so he could just say yes and a day later would blow away. You said it and say work by sonars. Frequency, you can blow them up, you can do it. So tough thing to do. And so why at that point, whether he was deciding is this is going to be a long war, it's going to cost a lot of money. I'm going to go all the way. He's now moving a lot of American troops and equipment into Poland. I don't know if he's going to commit native to it. I don't know if NATO wants to go, but he basically gave Chancellor Schultz, took away the option of Schultz to say I'm going to stop giving them arms. Winter's coming. I want that pipeline. I want to keep my people warm and wealthy. So he blew it up. So there's been a lot of news reporting, a lot of interest on this very simple question. Who blew up the North Stream pipelines? Remember in September of last year, the North Stream One and N Stream Two, which are two parallelly running pipelines carrying natural gas from Russia to Germany, were blown up. There were massive explosions which happened 250 feet are below the sea. Now the first report that came out, which was last month by a famous American journalist, which seemed to suggest that this was an inside job, it was carried out by the United States using state actors. now just this past week there's been some follow up reporting
September the 26th last year and. I there was no way. Common sense. You have to deal with common sense. Well, let's see. I knew that no Russia would have done it because of Putin already had responded. There's two major pipelines, N Stream one, which has been alive for since 2011, and Nord Stream two, which is. These are huge. They moved millions of whatever the measurement is of natural gas. There is a different measurement and it's not cubic feet, it's they they they move in, they mouth stream one turn Germany because they supplied cheap natural gas. That was very clear. Then they needed it anyway. I'm just giving you all this because I'm not here. I can answer your question, but I be coming from the blue one. I don't want to come from the blue. I want people to understand I've done this a long time. So the White House, Mr. Hush, they have rejected your story outright. They've called it a figment of your imagination. More fiction than fact is the wording that they used. Germany has also taken a very cautious mind on your story. You referred before in your first answer to Western media like the New York Times, The Washington Post. Had you taken your story to the editors there, would they have published such a consequential story basis, Just one single, unnamed anonymous source? How would you react to that? This source? Would I the way described the story and the intent of how I sourced it? Was to be as as vague as possible. It would have been very
AboutAbout
As a Machine Learning Engineer, I am enthusiastic about exploring the fascinating field of machine learning and its potential applications in solving real-world problems. I have a good amount of knowledge in mathematics, statistics, and computer science, which enables me to understand and implement the fundamental concepts and techniques of machine learning.
My experience includes working with various data analytics tools and technologies, such as SQL, Python, Tableau, and Power BI. I have developed expertise in data cleaning and exploratory data analysis, statistical inference, and machine learning techniques such as regression, and clustering, my experience also includes working with a variety of machine learning tools and frameworks, including, Scikit-learn, TensorFlow and Keras. I have also developed expertise in data pre-processing, feature engineering, and model selection, which has enabled me to create robust and accurate machine-learning models.
I am eager to expand my knowledge and expertise in machine learning research and AI-related fields. I am a quick learner, and I am always willing to take on new challenges and stretch myself to develop new skills. Furthermore, I am a good communicator and collaborator, able to work effectively in a team and learn from more experienced colleagues.
I am excited about the potential of machine learning to create positive change and improve people's lives specifically in Health Care industries. I am committed to staying up-to-date with the latest developments in machine learning and related fields, attending conferences and workshops, and engaging in continuous learning. I am eager to apply my skills and experience to solve complex problems and create value for organizations.
https://www.linkedin.com/in/sudharmendra-gv-7214361b2/
Machine Learning EngineerMachine Learning Engineer
Longevity InTime BioTech · Part-timeLongevity InTime BioTech · Part-time
Nov 2022 - Present · 6 mosNov 2022 - Present · 6 mos
Wilmington, Delaware, United StatesWilmington, Delaware, United States
Longevity Intime is a company developing online technology, which enables early diagnosis of diseases using real-time biometrics from the human body.
The Longevity InTime team includes experienced biotechnologists, award-winning scientists, developers, and experienced executives with years of experience. Together we are solving the global problem of life expectancy for each person and for all mankind.
Our goal is to extend a person's life by more than 20 active and happy years without any restrictions to him. We respond to both the personal and public interests of every country on Earth.Longevity Intime is a company developing online technology, which enables early diagnosis of diseases using real-time biometrics from the human body. The Longevity InTime team includes experienced biotechnologists, award-winning scientists, developers, and experienced executives with years of experience.
Patent Number : 411898 Date of Patent : 24/05/2014
Application Number : 10903/DELNP/2015 Date of Grant : 21/11/2022
Type of Application : PCT NATIONAL PHASE APPLICATION Date of Recordal : 21/11/2022
Parent Application Number : --- Appropriate Office : DELHI
PCT International Application Number : PCT/JP2014/063758 PCT International Filing Date : 24/05/2014
Grant Title : VERTICAL AXIS WATER/WIND TURBINE MOTOR USING FLIGHT FEATHER OPENING/CLOSING WING SYSTEM
Sl No Name of Grantee Grantee Type Grantee Address
1 TAMATSU Yoshiji NATURAL PERSON Room16Toyota Apartment1656 5Aza OrokuNaha shi Okinawa 9010152
Sl No Name of Patentee Patentee Type Address of Patentee
1 TAMATSU Yoshiji NATURAL PERSON Room16Toyota Apartment1656 5Aza OrokuNaha shi Okinawa 9010152
Address of Service : Tech Corp. International Strategist TCIS, lndia 5th Floor, Caddie Commercial Tower, Aerocity, New Delhi- 110037 India
Additional Address of Service : --
Priority Date : 25/05/2013
Year Due dates for Renewal CBR No CBR Date Renewal Amount Renewal Certificate No Date of Renewal Renewal Period:
Normal Due Date Due Date with Extension From To
3rd year 21/02/2023 21/08/2023 12919 21/03/2023 800 27207 21/03/2023 24/05/2016 24/05/2017
4th year 21/02/2023 21/08/2023 12919 21/03/2023 800 27208 21/03/2023 24/05/2017 24/05/2018
5th year 21/02/2023 21/08/2023 12919 21/03/2023 800 27209 21/03/2023 24/05/2018 24/05/2019
6th year 21/02/2023 21/08/2023 12919 21/03/2023 800 27210 21/03/2023 24/05/2019 24/05/2020
7th year 21/02/2023 21/08/2023 12919 21/03/2023 2400 27211 21/03/2023 24/05/2020 24/05/2021
8th year 21/02/2023 21/08/2023 12919 21/03/2023 2400 27212 21/03/2023 24/05/2021 24/05/2022
9th year 21/02/2023 21/08/2023 12919 21/03/2023 2400 27213 21/03/2023 24/05/2022 24/05/2023
10th year 24/05/2023 24/11/2023 12919 21/03/2023 2400 27214 21/03/2023 24/05/2023 24/05/2024
11th year 24/05/2024 24/11/2024 12919 21/03/2023 4800 27215 21/03/2023 24/05/2024 24/05/2025
12th year 24/05/2025 24/11/2025 12919 21/03/2023 4800 27216 21/03/2023 24/05/2025 24/05/2026
13th year 24/05/2026 24/11/2026 12919 21/03/2023 4800 27217 21/03/2023 24/05/2026 24/05/2027
14th year 24/05/2027 24/11/2027 12919 21/03/2023 4800 27218 21/03/2023 24/05/2027 24/05/2028
15th year 24/05/2028 24/11/2028 12919 21/03/2023 4800 27219 21/03/2023 24/05/2028 24/05/2029
16th year 24/05/2029 24/11/2029 12919 21/03/2023 8000 27220 21/03/2023 24/05/2029 24/05/2030
17th year -- -- -- -- -- -- -- -- --
18th year -- -- -- -- -- -- -- -- --
19th year -- -- -- -- -- -- -- -- --
20th year -- -- -- -- -- -- -- -- --
Sl No Date of Entry Particulars/Remarks
Information u/s 146 (Working of Patents)
Sl No Patent Number Year
1 411898
TITLE OF INVENTION VERTICAL AXIS WATER/WIND TURBINE MOTOR USING FLIGHT FEATHER OPENING/CLOSING WING SYSTEM
FIELD OF INVENTION MECHANICAL ENGINEERING
E-MAIL (As Per Record) prity.khastgir@gmail.com
ADDITIONAL-EMAIL (As Per Record)
E-MAIL (UPDATED Online) khasip@khastgir.com
PCT INTERNATIONAL APPLICATION NUMBER PCT
Dear Sir/ Madam,
Congratulations, you have been shortlisted for our next phase of audition of Shark Tank India, which is the In-Person Audition! At this stage of the audition our team will be meeting you in-person to further discuss your business/idea. Please note, we will be conducting these “In-Person Auditions” in Mumbai, Bengaluru, Delhi & Kolkata.
As per your form, your audition city is Delhi
Audition Venue: WelcomHotel ITC Dwarka, Plot No 3, District Center, Sector 10 Dwarka, New Delhi, Delhi 110075.
Landline - 01142229222
Location – Welcomhotel Dwarka offers easy access to the Delhi Metro Blue Line near by metro station Dwarka Sector 10. Located 20 minutes away from Indira Gandhi International Airport and the domestic airport in New Delhi.
Audition Date & Time: 15th July'22 Friday at 1pm
Time commitment required: 4 hours on the audition day
Kindly note the following guidelines for the in-person audition -
COVID Mandatory Safety Guidelines:
Applicants and any accompanying persons will need to wear a mask at all times and adhere to all the social distancing guidelines communicated by us, while at the venue
In case, you and any accompanying persons are vaccinated please carry your updated vaccination certificate (first and second dosage) or the Arogya Setu Pass.
In case you and any accompanying persons are not vaccinated, RT PCR Test with a 48 hour validity is mandatory and the status will be checked prior to at the venue.
A mandatory Rapid Antigen Test will be administered at the venue and only if the same turns out to be negative, will the applicant be allowed to proceed further.
Please note, that all applicants and any accompanying person will at all times have to comply with the rules and regulations mandated by the Central or State Government with respect to COVID 19 prevention issued at that time.
Documents for verification required at the time of audition: -
(Please note the documents are required for verification at the time of audition, kindly carry original copies too & also please do email us these documents scanned copies before the audition date and also get it on your pen drive at the venue also. Email us on - sharktankindia1@setindia.com)
Mandatory
Applicant’s Photo Identity proof & Address Proofs (Aadhar Card & Pan-Card)
Document proofs to validate accreditation & Audited Financials - Balance Sheets, Net worth Certificate (if any) and Income Statement for last 3 years. Please note, the certificate should be taken from the CA/CA Firm (on their letterhead)
Certificates evidencing any change of name, Memorandum of Association, Articles of Association, registered partnership deed, etc. or equivalent documents
No Objection Certificate (NOC), signed & dated, from all shareholders/co-founders/partners/investors
Company PAN CARD/GST Certificates
Income Tax Returns for the last 3 years (according to the business tenure)
If Applicable
Certificate of Incorporation or registration for your firm/partnership/LLP/company
#Node CC: Philippe RochePhilippe Roche : 2nd Connect
Founding & Managing Partner
The distinction between private equity (PE) and venture capital (VC)
They differ in:
- Their amounts of investment
- Types of firms they choose to invest in
- Timing of their involvement in a company's lifespan
- Equity they receive as a result of their investments.
VCs often invest $10M or less.
PEs often spend $50 million or more.
Early-stage startups are the focus of VCs.
PEs focus on seasoned businesses.
A small portion of the corporation is owned by VCs.
PEs purchase a controlling stake from the stockholders.
VCs research exit strategies and fast growth.
PEs consider scaling businesses to increase productivity and profits.
Examples
VC firms: Bessemer Venture Partners, Andreessen Horowitz, and Sequoia Capital
VC-backed businesses: Juul, Stripe, SpaceX, Waymon, and Ripple Labs
Private equity firms: The Blackstone Group Inc., CVC Capital Partners, and TPG Capital are
Companies with PE backing: EQ Office, Panera Bread, and Refinitiv
PEs and VCs are, of course, much more complicated than this.
Please feel free to remark with your observations.
#startups #entrepreneurship #venturecapital #investing #finance #crossborder #inovexus #startup #VC #earlystage
#galeshapley
#smartcontracts
Ms. Prity Khastgir (b. 26 Dec. 1984). Obtained B.A.Sc (Hons) in Applied Sciences specialising in Food technology from University of Delhi and M.Sc in Biotechnology and LLB from University of Rajasthan. Did Entrepreneurship course from Indian School of Business (ISB) sponsored by Goldman Sachs 10,000 Women Entrepreneurs Initiative. She is Certified Mediator for Commercial Disputes and Negotiator in India. Currently, she is working towards launching innovation hub in
domestic and international level.
She is passionate about technology, law and business on a global scale. Recently, she was invited by China Government for China International Big Data Expo 2018, Guiyang. She is active in international technology arena and recently participated in the 4th Annual Asia Pacific Spectrum Management Conference and in World Summit on the Information Society (WSIS) Forum 2018, Geneva.
Senior executive profile with featured publications: BBC World, Nature Group (Nature Reviews Drug Discovery), BusinessWorld, BioSpectrum Asia etc. Previous work experience with US Law Firm headquartered in Greater New York City Area. Problem solver and Business Strategist with 12+ yrs exp. Seasoned Patent Strategist with expertise in IP portfolio research, cross-border tech transactions, licensing agreements, product clearance, FTO opinion, patent infringement and invalidity, IPR R&D Consultancy.
Aligning and facilitating youth to be driven in the industry 4.0 era is her motto to take India’s GDP to next level. She is a guest faculty at IMT, Ghaziabad taking lectures on legal aspects of doing business in India and understanding the innovation ethos globally.
#ITU Guide to drive Citizens' engagement for #Innovation #OpenGeneva
https://www.itu.int/net4/wsis/forum/2020/en/Agenda
Julia Dallest
Chief Operation Officer
Open Geneva
Julia Dallest is the Chief Operation Officer at Open Geneva. After 4 years as a change management consultant in Paris, Julia worked 2 years for a humanitarian mission in Madagascar as a partnership manager. Wishing to continue her involvement in the associative world, Julia joined Open Geneva as a volunteer in 2018 and as Chief Operation Officer since 2019.
Cristina Bueti
Counsellor of ITU-T Study Group 20 “Internet of things (IoT) and smart cities and communities (SC&C)”
International Telecommunication Union
Cristina Bueti is the Counsellor of ITU-T Study Group 20 “Internet of things (IoT) and smart cities and communities (SC&C)” at the International Telecommunication Union (ITU). She is responsible for ITU-T's activities on IoT and smart sustainable cities. She is the ITU focal point for environment and climate change including e-waste management. She also serves as TSB focal point for Latin America.
Cristina Bueti graduated from the Faculty of Political Science, Law and International Cooperation and Development of the University of Florence, where she completed postgraduate studies in International Cooperation and Telecommunications Law in Europe. She also holds a specialization in Environmental Law with a special focus on Telecommunications.
In 2003, Ms. Bueti built on her academic credentials by completing a specialized course in peace keeping and international cooperation with special focus on telecommunications at the Faculty of Laws, University of Malta, before joining the International Telecommunication Union in Geneva in January 2004.
As part of the International Women's Day 2016, she was named as one of the twenty Geneva-based inspirational women working to protect the environment.
She has authored over 40 reports on telecommunication issues. A native Italian speaker, Cristina is also fluent in English, French and Spanish.
Thomas Diez
FabCity
Venezuelan Urbanist specialized in digital fabrication and its implications on the future cities and society. He is the co-founder and director of Fab Lab Barcelona at the Institute for Advanced Architecture of Catalonia (IAAC), and is a founding partner of the Fab City Global Initiative. He is also the director of the recently launched Master in Design for Emergent Futures at IAAC. Tomas has been appointed by The Guardian and Nesta as one of the top 10 digital social innovators to watch in 2013, and has been awarded by the Catalan ICT association as the entrepreneur of the year in 2014.
More from Prity Khastgir IPR Strategic India Patent Attorney Amplify Innovation (20)
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
2. http://www.techcorplegal.com
Email us: info@techcorplegal.com Follow Us
Probiotic literally means “for life.” The Joint
Food and Agriculture Organization/World Health
Organization defines probiotics as “live
microorganisms which, when administered in
adequate amounts, confer a health benefit on the
host.”
WHAT ARE
PROBIOTICS ?
3. http://www.techcorplegal.com
Email us: info@techcorplegal.com Follow Us
Probiotics have been shown to have beneficial effects against various
diseases and disorders, most common are:
• Gastrointestinal disorders
• Allergies- Skin, respiratory, food
• Cardiovascular diseases
• Metabolic disorders like Diabetes
• Obesity and overweight
• Urinogenital infections
• Kidney disorders
• Neurological disorders.
BENEFITS OF
PROBIOTICS
4. http://www.techcorplegal.com
Email us: info@techcorplegal.com Follow Us
DEVELOPMENT OF
MUCOSAL
BARRIER
PRODUCTION OF
SHORT-CHAIN
FATTY ACIDS
METABOLISM OF
BILE ACIDS
REDUCTION OF pH
IN LARGE BOWEL
SYNTHESIS OF
VITAMINS
IMMUNE SYSTEM
ACTIVATION
PROBIOTICS
BENEFITS
5. http://www.techcorplegal.com
Email us: info@techcorplegal.com Follow Us
Inventions in the field of probiotics include-
❖ Method for isolating/extracting/conditioning/modifying live
micro-organisms including various strains of bacteria and
yeast
❖ New strains of bacteria and yeast
❖ Compositions/formulations/products comprising micro-
organisms
❖ Use of probiotics
PATENTABLE
SUBJECT MATTER
6. http://www.techcorplegal.com
Email us: info@techcorplegal.com Follow Us
CRITERIA FOR
PATENTABILITY
The relevant sections of the Patent Act applicable for
ascertaining patentability of probiotic related
invention are:
Section 3(c): the mere discovery of a scientific
principle or the formulation of an abstract theory or
discovery of any living thing or non-living substance
occurring in nature.
7. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Section 3(d): the mere discovery of a new form of a known
substance, which does not result in the enhancement of the
known efficacy of that substance or the mere discovery of any
new property or new use for a known substance or mere use of a
known process, machine or apparatus unless such known process
results in a new product or employs at least one new reactant.
CRITERIA FOR
PATENTABILITY
8. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
CRITERIA FOR
PATENTABILITY
Section 3(i): any process for the medicinal,
surgical, curative, prophylactic [diagnostic,
therapeutic] or other treatment of human beings
or any process for a similar treatment of animals to
render them free of disease or to increase their
economic value or that of their products;
9. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
CRITERIA FOR
PATENTABILITY
Section 3(j):plants and animals in whole or any part
thereof other than micro organisms but including
seeds, varieties and species and essentially
biological processes for production or propagation of
plants and animals;
10. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
CRITERIA FOR
PATENTABILITY
Section 3(p): an invention which, in effect, is
traditional knowledge of which is an aggregation or
duplication of known properties of additionally known
component or components.
12. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
PROBIOTICS – AN INDIAN
SCENARIO
Within the functional foods, probiotics is the rapidly expanding, active
arena. In probiotic revolution, India can play a key role as being the
largest producer of milk and having world’s highest cattle
population. Indian probiotic industry is in its infancy stage and presently
accounts for only a small fraction i.e. less than 1% of the total world
market turnover in the probiotic industry. But Probiotic industry is
evolving at a steady pace with conditions set for tremendous growth in
near future.
13. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Active Players in
Probiotics in India
1. Chr. Hansen (India) Pvt. Ltd.
2. Danone foods & beverages (India) Pvt. Ltd.
3. Mother Dairy fruits and vegetables private limited
4. Micrbax(India) ltd.
5. Nestle India ltd.
6. Yakult Danone India Pvt ltd.
7. Zytex Biotech Pvt. Ltd.
8. Shree Additives Pharma and Foods Limited
19. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR
CHEESE SUBSTITUTES; MAKING THEREOF (obtaining protein
compositions for foodstuffs A23J 1/00; preparation of peptides, e.
g. of proteins, in general C07K 1/00)
INTERNATIONAL
PATENT
CLASSIFICATION (IPC):
A23C
20. Follow Us
GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A23C
No. Application No. Patent No. Title of Invention
Date of Filing
(National)
1 1359/MUMNP/2010 260159 Stable nutritional powder 25/06/2010
2 245/MUMNP/2009 258316 Polyphenol/peptide composition and use thereof for promoting gastric health 2/2/2009
3 480/DEL/2006 258152 A method for the estimation of multi residue in milk & milk products 22/02/2006
4 1078/DEL/2006 257783 "a process for the preparation of low cholesterol ghee". 27/04/2006
5 5536/DELNP/2006 257376 "a water or milk based liquid product comprising living micro-organisms". 22/09/2006
6 3653/CHENP/2006 257233 An apparatus for the evaporative cooling of a liquid product 3/10/2006
7 2685/DELNP/2007 257203 Infant formula comprising beta serum or / and fraction obtained from beta serum 11/4/2007
8 1403/MUMNP/2008 257124 A self-stable beverage composition 7/7/2008
9 1181/DEL/2007 257068 Process for manufacture of spray dried cheddar flavour base/concentrate 1/6/2007
10 1362/CHENP/2007 257045 Fermented food material comprising receptor ligand 3/4/2007
11 4435/CHENP/2006 254520 Enzymatic process for obtaining increased yield of lactobionic acid 1/12/2006
12 97/KOLNP/2007 253828
Food ingredients and food products treated with an oxidoreductase and methods for preparing
such food ingredients and food products 8/1/2007
13 1617/MUM/2007 253269 Lecithinisation process for preparation of milk based powder bevarage with micronutrients 24/08/2007
14 2180/MUM/2007 253078
A process for the perparation of novel molecular dispersions of lipophilic nutrients and a product
obtained thereof 1/11/2007
15 2834/KOLNP/2008 252856 Method for producing fermented milk using novel lactic acid bacteria 11/7/2008
21. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
No. Application No. Patent No. Title of Invention
Date of Filing
(National)
16 2666/CHENP/2007 252330 Method for producing fractions of a milk composition 20/06/2007
17 3279/KOLNP/2006 251851 Cheese and methods of making such cheese 9/11/2006
18 150/CHENP/2006 249788 Powderous formulations of fat-soluble active ingredients 12/1/2006
19 3724/KOLNP/2006 249636 Acidic milk drink 11/12/2006
20 489/DEL/2004 249174 A process for the preparation of spray dried norbixin powder 16/03/2004
21 738/DEL/2005 248474 A process for corn flour biscuits 31/03/2005
22 1657/MUM/2008 247578 A process for deoiling liquid lecithin using rotating disc contactor 4/8/2008
23 2227/DEL/2005 245014 "a process for the preparation of processed cheese spread" 19/08/2005
24 745/DEL/2005 243804 A process for the preparation of a novel bio-curd 31/03/2005
25 1433/DEL/1999 243797 "process for the detection of synthetic milk" 2/11/1999
26 468/DEL/2004 240948 A packaging process for extension of shelf life of milk based products 16/03/2004
27 600/MUMNP/2007 239473 Carbonated protein drink and method of making 25/04/2007
28 IN/PCT/2002/1301/CHE 235254 Process for the preparation of milk powder 20/08/2002
29 155/MUMNP/2006 234855 Fermented food product comprising soy protein 8/2/2006
30 929/CHENP/2004 234584 A method for the preparation of a fermented dairy product 30/04/2004
GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A23C
22. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
No. Application No. Patent No. Title of Invention
Date of Filing
(National)
31 842/DELNP/2006 234280 "a composition comprising a strain of lactic acid bacteria" 20/02/2006
32 3377/DELNP/2005 233464 "a method for treating dairy process stream" 28/07/2005
33 1809/DELNP/2005 233280 A beverage composition 3/5/2005
34 2626/CHENP/2005 229760 A nutritionally complete composition 13/10/2005
35 518/CHENP/2005 226665
A method for producing acid coagulation-resistant milk and increasing its calcium
absorbability and the milk 1/4/2005
36 2707/CHENP/2004 226363 Method for producing whey protein hydrolysate 30/11/2004
37 379/KOLNP/2003 225437 A dairy product and a mehtod for manufacturing thereof 1/4/2003
38 1193/CHENP/2003 224869 A method of increasing the solubility or dispersibility of a powder or a tablet 1/8/2003
39 963/CHENP/2004 223679 A method for producing a modified whey protein preparation 5/5/2004
40 1451/DELNP/2004 218049 "imitation cheese composition" 28/05/2004
41 2233/DELNP/2003 217544 "a mehtod for producing an imitation cheese composition" 22/12/2003
42 IN/PCT/2001/1474/CHE 216428 Shelf-stable calcium fortified milk and dairy products 23/10/2001
43 IN/PCT/2000/343/CHE 215934 An apparatus in an infusor for a liquid food product 4/9/2000
44 IN/PCT/2000/342/CHE 215933 An apparatus in an infusor for a liquid food product 4/9/2000
45 IN/PCT/2001/789/CHE 212338 A process for reducing free fatty acid present in an anhydrous liquid animal fat 7/6/2001
GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A23C
23. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
No. Application No. Patent No. Title of Invention
Date of Filing
(National)
46 IN/PCT/2002/1972/CHE 209522
A process for preparation of a composition containing exogenous lactic bacteria strains
against actinomyces naeslundii related disease 29/11/2002
47 1250/MUM/2003 206340 A process for low carbohydrate sweetener 8/12/2003
48 607/MUM/2003 206338 An improved process of production of channa podo 11/6/2003
49 IN/PCT/2002/01178/KOL 203629 "nutritional mineral fortification of milk" 18/09/2002
50 IN/PCT/2002/141/CHE 201814 Foaming ingredient and powders containing it 25/01/2002
51 548/MAS/1997 196347 Method and device for dissolving 17/03/1997
52 41/MAS/1993 181165
A method of producing a soya drink possessing superior flavour and stcrage properties
on a rational industrial scale 25/02/1993
GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A23C
24. http://www.techcorplegal.com
Email us: info@techcorplegal.com Follow Us
FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES,
NOT COVERED BY SUBCLASSES A21D OR A23B-A23J;
THEIR PREPARATION OR TREATMENT, e.g. COOKING,
MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL
TREATMENT (shaping or working, not fully covered by this
subclass, A23P); PRESERVATION OF FOODS OR
FOODSTUFFS, IN GENERAL (preservation of flour or dough for
baking A21D)
INTERNATIONAL PATENT
CLASSIFICATION (IPC):
A23L
25. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A23L
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 2031/DEL/2004 260347 "aldehyde as perfuming or flavoring ingredient" 18/10/2004
2 1129/MUMNP/2009 260196
An instant food having a particulate phase and a soluble phase with selective sodium
distribution 15/06/2009
3 1466/MUMNP/2008 260194 Aerated composition comprising hydrophobin 11/7/2008
4 295/MUMNP/2009 260192 Self-stable liquid satiety enhancing composition 9/2/2009
5 959/MUMNP/2010 260190 Calcium-fortified beverage and method of making thereof 10/5/2010
6 1362/MUMNP/2010 260168 Stable nutritional powder 25/06/2010
7 5751/DELNP/2007 260045 Powder compositions 24/07/2007
8 726/DEL/2005 260018 A formulation of ready to eat onion bar 31/03/2005
9 3071/DELNP/2007 259714
Compositions containing fat-soluble active ingredients and/or colorants in a matrix based on
modified plant gums 24/04/2007
10 307/DEL/2006 259671 A process for the preparation of ready-to-use cereal flakes coated with meat powder 3/2/2006
11 5944/DELNP/2007 259432 "process for preparing nutritional products" 30/07/2007
12 8582/DELNP/2007 259269 "a food material" 6/11/2007
13 6481/DELNP/2007 259265 “an infant nutrition composition with probiotics” 21/08/2007
14 714/DELNP/2007 259261 Novel feed or food composition. 25/01/2007
15 1767/MUMNP/2010 259170
Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and
amelioration of osteoporosis 19/08/2010
27. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A23K
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 1750/DEL/2006 259068 Method for manufacturing a composite tire of polyurethane tread and a radial carcase 31/07/2006
2 665/DEL/2006 257926 A process for the preparation of dog chews 10/3/2006
3 1528/MUM/2008 257272 Process for preparation of phenoxypropanol amines 18/07/2008
4 6269/DELNP/2006 256852 "processes for preparing plant matter extracts " 25/10/2006
5 4082/DELNP/2004 256682 Pressure formed pet food and method of manufacture 22/12/2004
6 175/MUMNP/2010 254915 Mycotoxin sorbent and method for preparing the same 29/01/2010
7 3750/DELNP/2006 253032 "a food and feed supplement" 29/06/2006
8 1076/KOLNP/2007 252308 Method for pigment solubilisation and a pigment composition 27/03/2007
9 4413/DELNP/2006 252178 "calcium fortification of bread dough" 31/07/2006
10 974/CHENP/2006 252069 Vitamin containing pet food compositions 20/03/2006
11 5293/DELNP/2006 251580 "compositions and methods for reducing or preventing obesity" 13/09/2006
12 3105/DELNP/2004 250290 "a process for obtaining a food product" 11/10/2004
13 298/KOL/2007 249674 Golden bird soap 28/02/2007
14 2020/CHE/2007 247304
Universal semi synthetic diet for young instar silkworm, multi x bivoltine hybrids of silkworm
bombyx mori 10/9/2007
15 3998/DELNP/2004 246107 "a highly palatable,nutririonally complete,essentially vegetarian pet food" 15/12/2004
30. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET
PURPOSES (devices or methods specially adapted for bringing
pharmaceutical products into particular physical or administering
forms A61J 3/00; chemical aspects of, or use of materials for
deodorisation of air, for disinfection or sterilisation, or for
bandages, dressings, absorbent pads or surgical articles A61L;
soap compositions C11D)
INTERNATIONAL PATENT
CLASSIFICATION (IPC):IPC
A61K
31. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A61K
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 1015/MUMNP/2009 260139 A compound of the general formula l-m-v 25/05/2009
2 1014/DELNP/2008 260065 An article of manufacture 5/2/2008
3 1010/KOLNP/2007 260039 Multi-purpose bio-material composition 21/03/2007
4 1201/DEL/2000 259773
Heavier halogen atom substituted squaraine based dyes useful as sensitizers for
photodynamic therapeutical and industrial applications 26/12/2000
5 1127/MUMNP/2009 259287 Antiperspirant stick compositions 15/06/2009
6 1411/CHE/2006 259181 Method for extraction of chemoprotectants from crucifer seeds and sprouts 7/8/2006
7 1528/CHENP/2007 259045 Hair care formulations comprising aminofunctional polyorganosiloxane 16/04/2007
8 1294/DELNP/2007 258802 "polypeptide comprising an amino acid sequence and conjugate comprising said polypeptide" 19/02/2007
9 1507/CHENP/2007 258580 Dialysis solution, formulated and stored in two parts, comprising phosphate 13/04/2007
10 1172/CHENP/2008 258416 Trazodone composition for once a day administration 7/3/2008
11 1331/KOLNP/2006 258332 Benzimidazoles useful as modulators of ion channels 18/05/2006
12 1081/MUMNP/2009 258284 Oral care product 5/6/2009
13 1438/DEL/2005 258190
"adirect-acting or nitric oxide donor based respiratory formulation for management of
pulmonary hypertension & other hypoxic and a process for the preparation thereof" 3/6/2005
14 1355/CHE/2005 258108 An improved process for the preparation of an ace inhibitor 26/09/2005
15 1492/CHE/2005 257939 Piperazinyl compounds as hdac inhibitors 18/10/2005
32. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS
IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF
AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT
PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES,
DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES (preservation
of bodies or disinfecting characterised by the agent employed A01N;
preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical,
dental or toilet purposes A61K)
INTERNATIONAL PATENT
CLASSIFICATION (IPC):
A61L
33. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A61L
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 6463/DELNP/2007 260336 "wound care device" 21/08/2007
2 2895/KOLNP/2006 260314
A method for the production of a biologically active prosthetic device for the reconstruction of
bone tissue and the prosthetic device itself 9/10/2006
3 897/DELNP/2007 260073 "tissue-adhesive materials" 2/2/2007
4 2953/DELNP/2006 260025 "method and system for identifying a communication interface of an electronic unit" 23/05/2006
5 6314/DELNP/2006 259999 "azeotrope-like compositions of tetrafluoropropene and hydrofluorocarbons" 27/10/2006
6 672/DELNP/2006 259418 " sterilant system " 8/2/2006
7 4866/DELNP/2007 259338 "medical tubes" 25/06/2007
8 2585/KOLNP/2009 259172 Method for sterilizing containers 14/07/2009
9 4995/DELNP/2007 259126 "multilayer dressing" 28/06/2007
10 6762/DELNP/2007 258719 "a multilayer structural body and a process for preparing the same thereof" 31/08/2007
11 4579/CHENP/2006 258049 Polymeric coupling agents and pharmaceutically-active polymers made therefrom 14/12/2006
12 410/KOLNP/2008 257972 A method for producing an anti-adhesion material 29/01/2008
13 7101/DELNP/2006 257604 A method for inactivating a virus contained in a sample 27/11/2006
14 01164/DELNP/2003 257504 " a coated collagen carrier" 25/07/2003
15 428/DEL/2007 257364 "a biological indicator to assess steam sterilization of foods" 27/02/2007
34. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
(introducing media into or onto the bodies of animals A61D 7/00; means for
inserting tampons A61F 13/26; devices for administering food or medicines
orally A61J; containers for collecting, storing or administering blood or medical
fluids A61J 1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR
TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of
surgical articles A61L; magnetotherapy using magnetic elements placed within
the body A61N 2/10); DEVICES FOR PRODUCING OR ENDING SLEEP OR
STUPOR
INTERNATIONAL PATENT
CLASSIFICATION (IPC):
A61M
35. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A61M
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 1627/CHENP/2007 260293 Device for needleless injection operating with two concentric energetic materials 20/04/2007
2 4421/CHENP/2006 260150 a flexible bag for medical use for infusing medication by gravity 1/12/2006
3 4008/DELNP/2004 259907 "an infusion device " 16/12/2004
4 3205/CHENP/2007 259474
Apparatus and method for facilitating the transmission of vapour particles directly into a nasal
passage 20/07/2007
5 2589/KOLNP/2006 259384 A dispensing device eg. An inhaler for dispensing of a dose of a medicament 8/9/2006
6 1893/DELNP/2005 259366 "needle apparatus" 5/5/2005
7 297/MUMNP/2008 259324 Injection device 18/02/2008
8 2946/DELNP/2004 259253 "tool honder for flexibly-deformable tool" 29/09/2004
9 6696/DELNP/2006 259220 "blood drawing device" 13/11/2006
10 364/DEL/2007 259198 A surgical system comprising a surgical cassette 21/02/2007
11 3297/DELNP/2004 259115 "a device for delivering a powdery medicine into the nasal cavity" 25/10/2004
12 5543/DELNP/2007 258997 A method for harvesting a product from a cell culture by diafiltration. 18/07/2007
13 3623/CHENP/2006 258977 A breastshield for a breastpump 28/09/2006
14 1019/CHENP/2007 258699 A highly water permeable hollow fiber membrane type blood purifier 9/3/2007
15 5606/DELNP/2005 258602 "intradermal drug delivery device" 2/12/2005
37. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : A61P
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 1123/DELNP/2008 260247
"ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal
re-epthelization" 8/2/2008
2 355/KOLNP/2007 260226 Lysis/resealing process for preparing erythrocytes 1/2/2007
3 786/MUMNP/2009 259851
Piperidine or piperazine substituted tetrahydro-naphthalene-1- carboxylic acid mtp inhibiting
compounds 22/04/2009
4 1856/MUMNP/2010 259828 “3-indazolyl-4-pyridylisothiazoles” 1/9/2010
5 4144/KOLNP/2008 259748
Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for
cardiovascular disorders 13/10/2008
6 586/DELNP/2007 259640 Vaccines against aids comprising cmv/r-nucleic acid constructs. 22/01/2007
7 2562/MUMNP/2010 259636 “filtration method” 30/11/2010
8 882/DEL/2003 259594 "mutants of mycobacteria and process thereof" 9/7/2003
9 6013/DELNP/2006 259582
Inhalable powders containing 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-
ethylamino]-ethyl}-4h-benzo[1,4]oxazin of general formula 1a 16/10/2006
10 862/MUM/2008 259153 A process for preparation of topical pharmaceutical composition 16/04/2008
11 1057/CHE/2006 259104 A method for producing biologically active polypeptide having insulinotropic activity 21/06/2006
12 1861/MUMNP/2010 258938 Anti-trka antibody 1/9/2010
13 2252/MUMNP/2009 258919 “compounds and methods for modulating fxr” 3/12/2009
14 97/MUM/2009 258915 An arteether injection for treatment of malaria 14/01/2009
4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)
40. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides,
pest repellents or attractants, or plant growth regulators containing
micro-organisms, viruses, microbial fungi, enzymes, fermentates, or
substances produced by, or extracted from, micro-organisms or animal
material A01N 63/00; medicinal preparations A61K; fertilisers C05F);
PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS;
MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological
testing media C12Q 1/00)
INTERNATIONAL PATENT
CLASSIFICATION (IPC):
C12N
41. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : C12N
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 9301/DELNP/2008 260327 "multimer for immunostimulation" 6/11/2008
2 4392/KOLNP/2007 260322 Novel sesquiterpene synthases and method 15/11/2007
3 7719/DELNP/2007 260305 Expression of proteins in plants 8/10/2007
4 2298/DELNP/2007 260264 "methods and compositions to inhibit p2x7 receptor expression" 23/03/2007
5 1592/MUMNP/2010 260143 A method for preparing a stable and viable re-cross linked biocatalyst of penicillin g acylase 23/07/2010
6 707/MUMNP/2009 260142
Method for producing blood cells using a structure enclosing hematopoietic progenitor cells
from es cells 13/04/2009
7 1818/DEL/2006 260063
"a process of preparing consortium of bacteriophages useful for controlling luminous bacterial
disease in shrimp larvae". 11/8/2006
8 6575/DELNP/2007 260017 Process for the production of vitamin c 24/08/2007
9 6595/DELNP/2006 259915 "a recombinant eukaryotic host cell producing human-like glycoproteins” 8/11/2006
10 2840/KOLNP/2007 259862 Compound for activating nkt cells 3/8/2007
11 1372/DELNP/2006 259687 Process for producing rose plant cell with modified color 13/03/2006
12 1350/CHENP/2008 259649 Protein a production and purification without using animal derived components 19/03/2008
13 744/DELNP/2007 259630
"a dopaminergic neuron proliferative cell marker probe, antibody, reagent and method for
selecting thereof" 29/01/2007
14 9252/DELNP/2007 259627 "modified microorganisms with inactivated lactate dehydrogenase gene" 30/11/2007
15 6006/DELNP/2007 259575 "method for obtaining site specific recombination in a eukaryotic cell" 1/8/2007
42. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A
DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE
OPTICAL ISOMERS FROM A RACEMIC MIXTURE (fermentation processes
to form a food composition A21, A23; compounds in general, see the relevant
compound class, e.g. C01, C07; brewing of beer C12C; producing vinegar
C12J; processes for producing enzymes C12N 9/00; DNA or RNA concerning
genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or
purification C12N 15/00)
INTERNATIONAL PATENT
CLASSIFICATION (IPC):
C12P
43. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : C12P
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 4392/KOLNP/2007 260322 Novel sesquiterpene synthases and method 15/11/2007
2 452/CHE/2008 260312 Method for the production of ethanol from muntingiya calabura 22/02/2008
3 479/DELNP/2007 260273 Process for biochemical synthesis of 1,4-butanediamine 17/01/2007
4 478/DELNP/2007 260246 Biochemical synthesis of 1,4-butanediamine 17/01/2007
5 843/KOLNP/2008 259357
Process for production of optically active (s or r)-α-amino acid or optically active (s or r)-α-
amino acid ester 26/02/2008
6 4325/DELNP/2007 259127 Process for the synthesis of cefaclor 6/6/2007
7 4509/DELNP/2006 258905 "process for large scale production of plasmid dna by e. Coli fermentation" 4/8/2006
8 7318/DELNP/2007 258867 Process for microbial production of a valuable compound 21/09/2007
9 3023/DELNP/2007 258837 "method for producing chiral alcohols" 23/04/2007
10 7954/DELNP/2007 258815 "integration of alternative feedstreams in biomass treatment and utilization" 16/10/2007
11 2669/MUMNP/2008 258729 A recombinant fusion protein and processes for producing the same 16/12/2008
12 2178/DELNP/2007 258566 "a polypeptide selected from the group consisting" 21/03/2007
13 1812/DELNP/2008 258414 "microbial host cells for the fermentive production of 1- butanol" 29/02/2008
14 848/MUMNP/2009 258202 A method for the preparation of hollow cellulose vessels 30/04/2009
15 5381/DELNP/2006 257967 Process for the preparation of calcium-d-pantothenate. 18/09/2006
44. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
MEASURING OR TESTING PROCESSES INVOLVING
ENZYMES OR MICRO-ORGANISMS (immunoassay G01N
33/53); COMPOSITIONS OR TEST PAPERS THEREFOR;
PROCESSES OF PREPARING SUCH COMPOSITIONS;
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL
OR ENZYMOLOGICAL PROCESSES [3]
INTERNATIONAL PATENT
CLASSIFICATION (IPC):
C12Q
45. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : C12Q
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 2974/DEL/2005 260097
"an apparatus and method for selectively attracting and inbhiting attraction of at least one
molecule to a site in a molecular detection device" 8/11/2005
2 7202/DELNP/2008 260090 High throughput testing for presence of microorganisms in a biological sample 22/08/2008
3 1056/DEL/2006 259883 "a solar poultry housing structure for commercial poultry rearing in cold arid zones" 24/04/2006
4 2840/KOLNP/2007 259862 Compound for activating nkt cells 3/8/2007
5 7291/DELNP/2006 259641 "genotoxic testing" 4/12/2006
6 2154/MUMNP/2008 259464 A protease detection product 7/10/2008
7 3621/DELNP/2007 259313
"reagents and methods for improving reproducibility and reducing mispriming in pcr
amplification" 15/05/2007
8 686/DELNP/2007 259214 "methods for exponentially amplifying dna" 25/01/2007
9 4010/DELNP/2006 259158 "method for manufacturing a peritoneal dialysis solution" 12/7/2006
10 2149/DELNP/2006 259135 "a method of producing a soild microparticle" 20/04/2006
11 1366/DEL/2007 258646 "a non-invasive dna isolation methodology in dairy animals" 26/06/2007
12 3038/DELNP/2008 258404 Composition for diagnosing prostate cancer in a patient 11/4/2008
13 3876/CHENP/2006 258396 Methods and compositions for analyzing ahasl genes 20/10/2006
14 2624/DEL/2006 258379
A set of novel oligonucleotide primers and the method for the detection of aspergillus
ochraceus thereby 7/12/2006
15 19/DELNP/2007 258235
"a kit for the detection of at least one mutation relating to a hiv-1 protein of reverse
transcriptase" 2/1/2007
47. GRANTED PATENT IN INTERNATIONAL
PATENT CLASSIFICATION (IPC) Class : C12R
No. Application Number
Patent
Number Title Of Invention
Date Of Filing
(National)
1 3292/KOLNP/2006 253485 "biotransformation of colchicinoid compounds". 9/11/2006
2 329/DEL/2006 250721 A process for microbial biotransformation of caffeine to theophylline 3/2/2006
3 1964/CHENP/2006 239912 Strain of rhodococcus rhodochrous ncimb 41164 and its use as producer of nitrile hydratase 2/6/2006
4 1087/DELNP/2005 228705 "plasmid-free clone of e. Coli strain dsm 6601" 18/03/2005
5 01390/KOLNP/2004 223784 Nucleotide sequence coding for a tolc and a defined amino acid sequence 20/09/2004
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
48. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Important point for
patent applicant
❏ Before filing for patent, the patent applicants should ascertain,
that the subject matter in respect of which a patent is sought,
does not fall under section 3 of the Indian Patent Act.
❏ In India, deposition of the microorganism isolated/ conditioned/
extracted/modified should be submitted at MTCC Chandigarh
or Pune.
❏ It is advisable to follow guidelines released by Indian Patent
Office.
49. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
DISCLAIMER
This post is no way related to Indian Patent office (IPO) or any of its
subsidiaries. All the posts/comments are only for general information or use and
it should not be relied on as official notice. Every care has been taken to ensure
the accuracy of information furnished in this post, authors do not accept any
responsibility or liability for any damage or loss arising from the direct or indirect
use of the contents provided on this post. We can be reached at info [at]
techcorplegal [dot] com
50. WHO ARE WE ?
Tech Corp Legal is a patent research and IP consulting firm that
specializes in assisting law firms and global companies to use Intellectual
Property as strategic business tool. Boutique Patent Attorney firm with a
high reputation in numerous technologies and high-tech patents. We are
reliable, knowledgeable and hands-on.
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Intellectual Property Consulting Law Firm in India
51. Mission: To assist Fortune 100 technology and research based
companies develop intellectual property strategies for betterment of
society.
Differentiating Factor: All projects are evidently done by registered
patent attorneys having years of experience in working under the
guidance of USPTO patent attorneys.
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
52. About Intellectual Property Experts
Rahul Dev is a Patent Attorney, Technology & Business
blogger, and partner of Tech Corp Legal LLP, an International
Law Firm. Click Here
Prity Khastgir is a Patent Attorney, specializing in Biotech,
Food Technology & Pharmaceuticals, and partner of Tech Corp
Legal LLP, an International Law Firm. Click Here
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
53. Client Testimonials
Mark Khan
Multi Disciplinary Designer/Creative Director
I have just met Prity in the past month. She
exceeded my expectations. Since I'm 1/2 way
around the world, I thought my patent filing in
India would be complex and mysterious. To read
more Click Here.
Charlotte Harrison
Editor at Nature Publishing Group
Prity was extremely helpful in providing expert
information and valuable comments for inclusion in a
news story related to patents in India. It was a pleasure
to work with her. To read more Click Here.
Vinayak Arora
Strategy Consultant at Strategy Consultant
Both Prity and Rahul supported us throughout
the patent filing process for our flagship product,
and gave proactive ideas on making the
application efficient. To read more Click Here.
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Kermit Lopez
Patent Attorney, ORTIZ & LOPEZ, PLLC
We needed a quick but detailed patent invalidity
analysis in a short time frame, and Rahul Dev,
Advocate, provided quick turn around To read
more Click Here.
54. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Client Testimonials
George Mathew
www.futurebooks.com
Rahul and team have been consistent in
their legal support to Servolve. Their
expertise in law and understanding of the
startup ecology is a unique mix that is not
easy to find. To read more Click Here.
David Sundin
SVB Environmental Lubricants, Ambit
Technical Consulting
I worked with Rahul to help me with
litigation regarding a competitor. He
easily understood the problem, did quick
and thorough work To read more Click
Here.
Dolly Goklaney Venture Capital at AMITY
Innovation Incubator
Rahul is a crisp speaker, possessed with
thorough knowledge and clear
understanding about the Business
Structuring & Incorporation, To read more
Click Here.
Farooq Mustafa Chaudhry
Macter International Ltd
After working on a project with Mr. Rahul
I have an impression that he is a
competent consultant in due diligence for
IP position To read more Click Here.
55. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Client Testimonials
Machiavelli Singh
Assistant Professor with Amity
University Haryana
Rahul Dev is a stalwart Indian patent
attorney, who dared to interpret the
Indian Patent "Novartis-Glivec-2013"
landmark case on NEWS channel in the
media with the iron fist, To read more
Click Here.
Kapil Agarwal
Owner, Swan Publications
Advocate Rahul Dev is a knowledgeable
lawyer and very helpful. He had gone
through my documents twice to provide
me an advice, To read more Click Here.
Pawan Tayla
Head Finance India - Fidelity Worldwide
Investment & Art of Living Teacher
Rahul is a very focused and energetic business
partner for any client, his ability to articulate and
provide quick meaning solutions is
commendable. To read more Click Here.
SUMIT ARORA
Deputy Manager - Intellectual Property Rights LG
Soft India
Rahul is a very diligent and hard working
professional who is adept at utilizing his
communication skills and domain knowledge in
excelling in his field. To read more Click Here.
56. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Client Testimonials
Dr. Vijay Soni
Director: reviewarticle.net
I recently got a patent applied through Mr.
Rahul. He has in-depth understanding of
all aspects of patent application and
processing. To read more Click Here.
Arjun Bala
Patent Agent, Certified Patent Valuation Analyst
(CPVA)
I have worked with Rahul on different types of patent
projects. He has a deep understanding as well as
practical insight in the practice of patent law in India.
To read more Click Here.
Raja Selvam
IP Attorney
Rahul is very obsessive about his work
and gets things done quickly and
efficiently. He has excellent co-ordination
and people relation skills. To read more
Click Here.
Preetpal Sidhu
Research Associate at Milwaukee Institute
I came to know Rahul during my internship at TECH
CORP. He is well organized with excellent knowledge
in his field. To read more Click Here.
57. http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Client Testimonials
Kapil Mishra
Kareus Therapeutics, S.A.
Rahul is a detail-oriented manager who
watches the fine details of project without
losing sight of the macro level strategic
objective. To read more Click Here.
Tarun Walia
Experienced Life Science Consulting &
Business Development Professional
The confidence and the charm on his face says it
all. Rahul is a well learned and extremely diligent
professional who drives his work with lot of
passion. To read more Click Here.Abhishek Mishra
Senior Manager at Olam International
Rahul, as a professional comes across as
a target oriented and a focussed
professional. He has a very structured
and planned approach and is full of
innovative ideas. To read more Click
Here.
Amit Midha
Digital Strategy, Marketing Expert
Rahul is a reliable professional with a very technical
approach towards commercial aspects of Patents
and IPR. To read more Click Here.
58. Client Testimonials
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Y. Yogi Raj
Co-Founder and Director at 46 Idea Street
We worked together during early stages of
establishing a new process. Rahul, with his
vast experience and in depth knowledge of the
IP analytics could steer our group, To read
more Click Here.
Dr Madhuresh Sethi Ph.D
R & D
Prity is a devoted and detailed professional
dealing with very complex assessments in
the field of Intellectual Property. To read
more Click Here.
Rolly Dureha Freelance Media Professional
& Consulting Editor
My interaction with Prity has been as a
Pharma patent attorney and domain expert
who has contributed towards articles in the
magazine Life Science India. To read more
Click Here.
David Michaels
eBusiness entrepreneur and Brand Consultant
Prity Khastgir is very dedicated, trustworthy, and
great at writing patent descriptions. Prity's patent
writing style is clear and concise.
60. Is Intellectual Property
a Business Asset?
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Protect
Create
SucceedProtect your Intangible
Assets Today !!
61. Thank you
Have Any Questions?
http://www.techcorplegal.com
Email us: info@techcorplegal.com
Follow Us
Get in touch with patent attorney:
info(at)techcorplegal(dot)com